首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method
【2h】

Study on the antiviral activity of San Huang Yi Gan Capsule against hepatitis B virus with seropharmacological method

机译:血清药理学研究三黄宜肝胶囊对乙型肝炎病毒的抗病毒活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSeropharmacology arising recently is a novel method of in vitro pharmacological study on Chinese herb using drug-containing animal serum. As seropharmacology possesses the advantages of experiments in vitro and in vivo, it is increasingly applied in pharmacological research on Chinese medicine. However, some issues of seropharmacology remain controversial and need to be clearly defined. San Huang Yi Gan Capsule (SHYGC) is a Chinese herbal formula with antiviral property against hepatitis B virus (HBV), but little is known about the mechanism underlying its anti-HBV activity. The aim of the present study was to elucidate the action mechanism of SHYGC using seropharmacological method and systematically address the methodology of preparing drug-containing serum.
机译:背景技术最近出现的血清药理学是使用含有药物的动物血清对中草药进行体外药理学研究的一种新方法。血清药理学具有体内外实验的优势,因此越来越多地应用于中药药理学研究。但是,一些血清药理学问题仍然存在争议,需要明确定义。三黄益肝胶囊(SHYGC)是一种中药配方,具有抗乙肝病毒(HBV)的抗病毒特性,但对其抗HBV活性的潜在机制了解甚少。本研究的目的是通过血清药理学方法阐明SHYGC的作用机理,并系统地探讨制备含药血清的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号